Ultragenyx Pharmaceutical Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Ultragenyx Pharmaceutical Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2013 to Q3 2024.
  • Ultragenyx Pharmaceutical Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $53.9M, a 93.1% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $53.9M +$26M +93.1% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $53.8M +$27.3M +103% Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $60M +$37.7M +169% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $57.7M +$9.35M +19.3% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $27.9M +$9.61M +52.6% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $26.5M +$5.35M +25.3% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $22.3M +$1.04M +4.91% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $48.3M +$27.8M +135% Dec 31, 2022 10-K 2024-02-21
Q3 2022 $18.3M +$1.87M +11.4% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $21.1M +$8.48M +66.9% Jun 30, 2022 10-Q 2022-07-29
Q1 2022 $21.2M +$12.3M +138% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $20.6M +$11.7M +133% Dec 31, 2021 10-K 2023-02-17
Q3 2021 $16.4M +$11.3M +222% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $12.7M +$10M +382% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $8.93M +$4.07M +83.6% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $8.81M +$5.34M +154% Dec 31, 2020 10-K 2022-02-15
Q3 2020 $5.09M +$1.98M +63.7% Sep 30, 2020 10-Q 2020-10-27
Q2 2020 $2.63M -$554K -17.4% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $4.86M +$2.2M +82.8% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $3.47M -$43K -1.22% Dec 31, 2019 10-K 2021-02-12
Q3 2019 $3.11M -$88K -2.75% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $3.18M -$58K -1.79% Jun 30, 2019 10-Q 2019-08-02
Q1 2019 $2.66M +$1.09M +69% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $3.51M +$107K +3.14% Dec 31, 2018 10-K 2020-02-14
Q3 2018 $3.2M +$1.85M +138% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $3.24M +$1.5M +86.6% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $1.57M -$188K -10.7% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $3.41M +$1.57M +85.5% Dec 31, 2017 10-K 2019-02-20
Q3 2017 $1.35M -$523K -28% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 $1.74M +$290K +20.1% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 $1.76M -$301K -14.6% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 $1.84M +$1.24M +209% Dec 31, 2016 10-K 2018-02-21
Q3 2016 $1.87M +$1.13M +154% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 $1.45M +$656K +83% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $2.06M +$1.28M +164% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $595K -$179K -23.1% Dec 31, 2015 10-K 2017-02-17
Q3 2015 $734K -$91K -11% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 $790K -$339K -30% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 $781K +$231K +42% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 $774K -$1.87M -70.8% Dec 31, 2014 10-K 2016-02-26
Q3 2014 $825K Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $1.13M Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $550K Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $2.65M Dec 31, 2013 10-K 2015-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.